General
Preferred name
PD099007
Synonyms
(-)-Syringaresinol 4-O-β-D-glucopyranosi ()
(-)-Syringaresinol 4-O-¦Â-D-glucopyranosi ()
Episyringaresinol 4'-O-¦Â-D-glncopyranoside ()
Episyringaresinol 4'-O-β-D-glncopyranoside ()
ACANTHOSIDE B ()
Episyringaresinol 4'-O-??-D-glncopyranoside ()
P&D ID
PD099007
CAS
137038-13-2
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Episyringaresinol 4'-O-¦Â-D-glncopyranoside (compound 22), isolated from Alhagi sparsifolia Shap, is a natural potential neuroinflammatory inhibitor[1].
PRICE
131
DESCRIPTION
Episyringaresinol 4'-O-??-D-glncopyranoside ((-)-Syringaresinol 4-O-??-D-glucopyranosi) inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, and may be a potential chemotherapeutic agent for cancer treatment.
DESCRIPTION
Episyringaresinol 4'-O-β-D-glncopyranoside ((-)-Syringaresinol 4-O-β-D-glucopyranosi) inhibits the proliferation of human promyelocytic HL-6 cells through G(1) arrest and induction of apoptosis, and may be a potential chemotherapeutic agent for cancer treatment.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
1
Compound Sets
2
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
10
Molecular Weight
580.22
Hydrogen Bond Acceptors
13
Hydrogen Bond Donors
5
Rotatable Bonds
9
Ring Count
5
Aromatic Ring Count
2
cLogP
0.68
TPSA
174.99
Fraction CSP3
0.57
Chiral centers
9.0
Largest ring
6.0
QED
0.28
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
